Litcius/Paper detail

EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)

Roberto C. Delgado Bolton, Nicolas Aide, Patrick M. Colletti, Annamaria Ferrero, Diana Páez, Andrea Skanjeti, Francesco Giammarile

2021European Journal of Nuclear Medicine and Molecular Imaging68 citationsDOI

Topics & Concepts

MedicineGuidelineDebulkingOvarian cancerStage (stratigraphy)RadiologyOvarian carcinomaDiseaseCancerInternal medicinePathologyPaleontologyBiologyOvarian cancer diagnosis and treatmentMRI in cancer diagnosisRadiomics and Machine Learning in Medical Imaging
EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA) | Litcius